F. Hoffmann-La Roche Ltd

Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022) Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al. Journal article Deep Learning-based Propensity Scores for Confounding Control in Comparative Effectiveness Research: A Large-scale, Real-world Data Study (2021) Weberpals J, Becker T, Davies J, Schmich F, Ruettinger D, Theis FJ, Bauer-Mehren A Journal article A machine learning perspective on the emotional content of Parkinsonian speech (2021) Sechidis K, Fusaroli R, Orozco Arroyave JR, Wolf D, Zhang YP Journal article Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution Phase II neoadjuvant study of GDC-9545+palbociclib (palbo) vs anastrozole (A) plus palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC) (2021) Hurvitz SA, Fasching P, Park YH, Quiroga V, Crnjevic TB, Fresco R, Lopez-Valverde V, et al. Conference contribution A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS (2021) Maccari ME, Fuchs S, Kury P, Andrieux G, Bengsch B, Lorenz MR, Heeg M, et al. Journal article Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021) Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al. Conference contribution Influence of Inter-Annotator Variability on Automatic Mitotic Figure Assessment (2021) Wilm F, Bertram CA, Marzahl C, Bartel A, Donovan TA, Assenmacher CA, Becker K, et al. Conference contribution Dataset on Bi- and Multi-nucleated Tumor Cells in Canine Cutaneous Mast Cell Tumors (2021) Bertram CA, Donovan TA, Tecilla M, Bartenschlager F, Fragoso M, Wilm F, Marzahl C, et al. Conference contribution Obinutuzumab-induced b cell depletion reduces spinal cord pathology in a cd20 double transgenic mouse model of multiple sclerosis (2020) Breakell T, Tacke S, Schropp V, Zetterberg H, Blennow K, Urich E, Kürten S Journal article